John Gordon McNeil MD PhD
HIV/AIDS Medicine, International Health, Travel & Tropical, Clinical Pharmacology, Clinical Informatics
Chief Medical Officer | EmitBio Inc.
Join to View Full Profile
4222 Emperor BlvdSuite 470Durham, NC 27703
Dr. McNeil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard School of Public HealthResidency, Occupational and Environmental Medicine, 1982 - 1989
National Capital Consortium Public Health and General Preventive MedicineResidency, Public Health and General Preventive Medicine, 1981 - 1989
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1981
Certifications & Licensure
MD State Medical License 1984 - 2025
Publications & Presentations
PubMed
- 13 citationsSafety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted ...Robert J. O'Connell, Jean-Louis Excler, Victoria R. Polonis, Silvia Ratto-Kim, Josephine H. Cox
The Journal of Infectious Diseases. 2016-06-15 - 2303 citationsVaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandSupachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Jaranit Kaewkungwal, Joseph Chiu
The New England Journal of Medicine. 2009-12-16 - 197 citationsSafety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialJohn J. Aponte, Pedro Aide, Montse Renom, Inacio Mandomando, Quique Bassat
Lancet. 2007-11-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
